Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1256788-36-9 | MDL No. : | MFCD18204709 |
Formula : | C7H5ClN2O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | XHQQYIWTUFWASX-UHFFFAOYSA-N |
M.W : | 168.58 | Pubchem ID : | 58503866 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.14 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 40.45 |
TPSA : | 45.91 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.02 cm/s |
Log Po/w (iLOGP) : | 1.94 |
Log Po/w (XLOGP3) : | 1.84 |
Log Po/w (WLOGP) : | 1.62 |
Log Po/w (MLOGP) : | 0.52 |
Log Po/w (SILICOS-IT) : | 1.94 |
Consensus Log Po/w : | 1.57 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.38 |
Solubility : | 0.699 mg/ml ; 0.00415 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.42 |
Solubility : | 0.634 mg/ml ; 0.00376 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.85 |
Solubility : | 0.239 mg/ml ; 0.00142 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.96 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280 | UN#: | N/A |
Hazard Statements: | H302-H312-H332 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | at 60℃; for 6 h; | Synthesis of 2-chloro-6-methoxy-pyridine-4-carbonitrile 25F A solution of compound 24 (2.0 g, 1 1.6 mmol) in methanol (20 mL) was added with sodium methoxyde (628 mg, 1 mol eq) and the mixture was heated at 60°C for 6h. The reaction was cooled, evaporated to dryness and then water was added (300 mL). The aqueous phase was extracted with EtOAc (3x25 mL) and the recombined organic phases were dried over sodium sulfate and evaporated under reduced pressure to afford 25F as transparent viscous oil (1.95g, quantitative yield). FontWeight="Bold" FontSize="10" HNMR (DMSO, 200 MHz) δ 3.80 (s, 3H), 7.17 (s, 1H), 7.90 (s, 1H). |
[ 121643-46-7 ]
6-Chloro-2-methoxynicotinonitrile
Similarity: 0.89
[ 25297-52-3 ]
2-Chloro-6-methoxy-4-methylpyridine
Similarity: 0.89
[ 193001-91-1 ]
(2-Chloro-6-methoxypyridin-4-yl)methanol
Similarity: 0.82
[ 95652-81-6 ]
6-Chloro-2-methoxynicotinaldehyde
Similarity: 0.76
[ 1008304-85-5 ]
2-Chloro-6-methoxypyridin-4-amine
Similarity: 0.75
[ 121643-46-7 ]
6-Chloro-2-methoxynicotinonitrile
Similarity: 0.89
[ 25297-52-3 ]
2-Chloro-6-methoxy-4-methylpyridine
Similarity: 0.89
[ 193001-91-1 ]
(2-Chloro-6-methoxypyridin-4-yl)methanol
Similarity: 0.82
[ 95652-81-6 ]
6-Chloro-2-methoxynicotinaldehyde
Similarity: 0.76
[ 121643-46-7 ]
6-Chloro-2-methoxynicotinonitrile
Similarity: 0.89
[ 65515-39-1 ]
2-Methoxy-4,6-dimethylnicotinonitrile
Similarity: 0.72
[ 1256835-79-6 ]
6-Chloro-5-methoxynicotinonitrile
Similarity: 0.69
[ 121643-46-7 ]
6-Chloro-2-methoxynicotinonitrile
Similarity: 0.89
[ 25297-52-3 ]
2-Chloro-6-methoxy-4-methylpyridine
Similarity: 0.89
[ 193001-91-1 ]
(2-Chloro-6-methoxypyridin-4-yl)methanol
Similarity: 0.82
[ 95652-81-6 ]
6-Chloro-2-methoxynicotinaldehyde
Similarity: 0.76